Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 3370
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT07753460 Low-Level Laser Therapy in the Treatment of Trigger Finger |
Low Level Laser Therapy | Myopathies | Non applicable | RECRUITING | En attente / non publié | Dokuz Eylul University | Turkey (Türkiye) · Dokuz Eylul University, Izmir, Tur… | 2025-08-07 → 2026-12 | Ouvrir |
| NCT06237595 Vagus Nerve Stimulation in Fibromyalgia |
Vagus nerve stimulation | Myopathies | Non applicable | COMPLETED | En attente / non publié | Stanford University | Egypt · Kasr Elainy Hospital, Cairo, Egypt | 2023-09-30 → 2025-03-15 | Ouvrir |
| NCT04833465 Development of a Therapeutic Endpoint in Pediatric Rheumatologic Condit… |
Development of a Therapeutic Endp… | Lupus | À vérifier | RECRUITING | En attente / non publié | Children's National Research Inst… | United States · Children's National Health System, Wa… | 2021-07-16 → 2028-12 | Ouvrir |
| NCT05624749 Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy … |
Ianalumab | Lupus | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Novartis Pharmaceuticals | United States, Argentina, Australia, Chile, Colombia,… | 2023-04-21 → 2029-04-09 | Ouvrir |
| NCT05639114 Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-… |
Ianalumab | Lupus | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Novartis Pharmaceuticals | United States, Argentina, Brazil, Bulgaria, Canada, C… | 2023-03-02 → 2029-03-23 | Ouvrir |
| NCT07598396 SOLUNA — A Study to Evaluate Mosunetuzumab in Participants With Systemi… |
Mosunetuzumab | Lupus | Phase 2 | RECRUITING | En attente / non publié | Hoffmann-La Roche | Brazil, Colombia, Italy, Mexico, South Africa · Admin… | 2026-05-25 → 2028-08-31 | Ouvrir |
| NCT07260877 AERIS — A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ph… |
VENT-03 | Lupus | Phase 2 | RECRUITING | En attente / non publié | Ventus Therapeutics U.S., Inc. | United States, Bulgaria, France, Georgia, Hungary, Po… | 2025-12-03 → 2026-09 | Ouvrir |
| NCT04877691 Tulip SC — Subcutaneous Anifrolumab in Adult Patients With Systemic Lup… |
Medi-546 | Lupus | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | AstraZeneca | United States, Argentina, Bulgaria, Chile, Colombia, … | 2021-06-08 → 2026-11-06 | Ouvrir |
| NCT07729995 BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Autoimmune Disea… |
LMY-922 | Lupus | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | Luminary Therapeutics | United States · Boston Children's Hospital, Boston, U… | 2026-10 → 2030-03 | Ouvrir |
| NCT07266090 A Study to Evaluate the Safety,Tolerability,Pharmacokinetics and Pharma… |
Cenerimod 4 mg | Lupus | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Viatris Pharmaceuticals Co., Ltd. | China · First Affiliated Hospital of Henan University… | 2026-01-14 → 2027-10-08 | Ouvrir |
| NCT07732309 ATTRACT — A Study of ATG-201 in Adult Participants With Autoimmune Dise… |
ATG-201 | Lupus | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | Antengene Biologics Limited | China · Huashan Hospital affiliated to Fudan Universi… | 2026-09-01 → 2029-06-01 | Ouvrir |
| NCT00756769 SLEIGH — Systemic Lupus Erythematosus in Gullah Health |
SLEIGH — Systemic Lupus Erythemat… | Lupus | À vérifier | RECRUITING | En attente / non publié | Medical University of South Carol… | United States · Medical University of South Carolina,… | 2003-04 → 2028-06 | Ouvrir |
| NCT07201558 ASSURO — Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in… |
Surovatamig | Lupus | Phase 1 | RECRUITING | En attente / non publié | AstraZeneca | United States, Australia, Belgium, Brazil, China, Ger… | 2025-12-02 → 2028-06-27 | Ouvrir |
| NCT03742037 Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in A… |
Cenerimod 0.5 mg | Lupus | Phase 2 | COMPLETED | En attente / non publié | Viatris Innovation GmbH | United States, Bulgaria, Chile, Czechia, France, Geor… | 2018-12-21 → 2022-08-25 | Ouvrir |
| NCT07201129 LUMIOS — A Research Trial to Assess if Cenerimod is Efficacious and Saf… |
Cenerimod | Lupus | Phase 3 | RECRUITING | En attente / non publié | Viatris Innovation GmbH | United States · Allied Biomedical Research Institute,… | 2026-02-09 → 2030-02 | Ouvrir |
| NCT04895696 A Study Evaluating the Efficacy and Safety of Afimetoran Compared With … |
Afimetoran | Lupus | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Bristol-Myers Squibb | United States, Argentina, Australia, Brazil, Chile, C… | 2021-10-11 → 2029-04-22 | Ouvrir |
| NCT05268289 Study of Efficacy and Safety of LNP023 in Participants With Active Lupu… |
Iptacopan (part 1) | Lupus | Phase 2 | RECRUITING | En attente / non publié | Novartis Pharmaceuticals | United States, Argentina, Brazil, China, Colombia, Fr… | 2022-08-10 → 2028-09-28 | Ouvrir |
| NCT05138133 IRIS — Phase 3 Study of Anifrolumab in Adult Patients With Active Proli… |
Anifrolumab | Lupus | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | AstraZeneca | United States, Argentina, Belgium, Brazil, Bulgaria, … | 2022-02-15 → 2028-10-04 | Ouvrir |
| NCT07762508 A Prospective Single-Arm Study of VABu Conditioning Regimen in Allo-HSC… |
Venetoclax | Cancer | Non applicable | NOT_YET_RECRUITING | En attente / non publié | TG Therapeutics, Inc. | China · First Affiliated Hospital of Soochow Universi… | 2026-08 → 2029-07 | Ouvrir |
| NCT07763756 Single vs Multiple Injection Intertransverse Process Block in Breast Ca… |
Multiple Level Intertransverse Pr… | Cancer | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Antalya City Hospital | Non communiqué | 2026-11-01 → 2027-09-01 | Ouvrir |
| NCT07008027 Real World Asparaginase Therapy Toxicity |
Real World Asparaginase Therapy T… | Cancer | À vérifier | NOT_YET_RECRUITING | En attente / non publié | St. Jude Children's Research Hosp… | United States · St. Jude Children's Research Hospital… | 2026-09 → 2031-07 | Ouvrir |
| NCT04431024 Prospective Evaluation of High Resolution Dual Energy Computed Tomograp… |
Prospective Evaluation of High Re… | Cancer | À vérifier | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · National Institutes of Health Clinica… | 2021-03-30 → 2038-06-30 | Ouvrir |
| NCT00068003 Harvesting Cells for Experimental Cancer Treatments |
Anti-CD19 CAR PBL | Cancer | À vérifier | ENROLLING_BY_INVITATION | En attente / non publié | National Cancer Institute (NCI) | United States · National Institutes of Health Clinica… | 2003-09-08 | Ouvrir |
| NCT05534386 A Self-management Based Survivorship Intervention for Chinese Cancer Su… |
A Self-management Based Survivors… | Cancer | Non applicable | RECRUITING | En attente / non publié | The University of Hong Kong | Hong Kong · Kwong Wah Hospital-Breast Center, Hong Ko… | 2023-04-12 → 2027-12-31 | Ouvrir |
| NCT05562518 GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRo… |
Estrogen | Cancer | Phase 4 | COMPLETED | En attente / non publié | University Hospital, Ghent | Belgium · University Hospital Ghent, Ghent, Belgium | 2022-03-21 → 2026-03-02 | Ouvrir |